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Although the physiological function of the ABCC6 protein is currently unknown, overwhelming experimental and 
genetic evidence supports its involvement in the pathogenesis 
of soft tissue calcification.1 ABCC6 is the gene mutated in 
pseudoxanthoma elasticum and generalized arterial calcifica-
tion of infancy.2,3 Because ABCC6 is mostly expressed in the 
liver, whereas aberrant calcification occurs in the periphery, 
pseudoxanthoma elasticum is considered a metabolic dis-
ease.4,5 Based on compelling evidence, ABCC6 is believed to 
be responsible for the sinusoidal efflux of a metabolite from 
the hepatocyte toward the bloodstream. In a recent article in 
Circulation Research, Martin et al6 have challenged this para-
digm, suggesting that ABCC6 is localized in the mitochon-
dria-associated membrane (MAM) and not in the plasma 
membrane (PM). Because MAM localization is inconsistent 
with published localization data7–10 and the presumed role of 
ABCC6, we conducted a series of experiments to confirm the 
cellular localization of the protein. In contrast to Martin et al,6 
we find that under physiological conditions ABCC6 indeed 
localizes to the basolateral membrane of hepatocytes and is 
not associated with MAM.
See Response, p e152
Methods
C57BL/6J mice (Jackson Laboratories) and Abcc6−/− mice11 were 
used. The experiments were approved by the Animal Care and Use 
Committee of the University of Hawaii and that of the Research Center 
for Natural Sciences, Hungarian Academy of Sciences. Human frozen 
liver sections were analyzed as approved by the Ethics Committee 
of Semmelweis University of Budapest. Negative controls were per-
formed on samples obtained from Abcc6−/− mice (Online Figure I). 
Further experimental details and the list of antibodies are shown in the 
online-only Data Supplement.
Results
Our aim was to use immunohistochemistry because this 
technique evaluates proteins in their native tissue environment. 
Given the sharp discrepancy between the findings of Martin 
et al6 and previously published work, we designed the 
experiments with special care. Immunohistochemistry was 
performed independently in 2 laboratories, with various 
monoclonal (M6II-7, M6II-24, M6II-68) and polyclonal (S-20) 
anti-Abcc6/ABCC6 antibodies and colocalization markers. Our 
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Rationale: ABCC6 plays a crucial role in ectopic calcification; mutations of the gene cause pseudoxanthoma 
elasticum and general arterial calcification of infancy. To elucidate the role of ABCC6 in cellular physiology and 
disease, it is crucial to establish the exact subcellular localization of the native ABCC6 protein.
Objective: In a recent article in Circulation Research, ABCC6 was reported to localize to the mitochondria-
associated membrane and not the plasma membrane. As the suggested mitochondrial localization is inconsistent 
with published data and the presumed role of ABCC6, we performed experiments to determine the cellular 
localization of ABCC6 in its physiological environment.
Methods and Results: We performed immunofluorescent labeling of frozen mouse and human liver sections, as 
well as primary hepatocytes. We used several different antibodies recognizing human and mouse ABCC6. Our 
results unequivocally show that ABCC6 is in the basolateral membrane of hepatocytes and is not associated with 
the mitochondria, mitochondria-associated membrane, or the endoplasmic reticulum.
Conclusions: Our findings support the model that ABCC6 is in the basolateral membrane, mediating the sinusoidal 
efflux of a metabolite from the hepatocytes to systemic circulation.  (Circ Res. 2013;112:e148-e151.)
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results show unambiguously that in frozen sections of mouse 
and human livers, Abcc6/ABCC6 is colocalized with the PM 
markers cadherin (Figure 1A and 1D) and catenin (not shown), 
as well as the basolateral membrane marker Na,K-ATPase 
(Figure 1B).
To further determine the subcellular location of ABCC6, we 
visualized the bile salt export pump (Bsep/Abcb11) that is ex-
pressed in the apical (canalicular) membrane of hepatocytes. 
Staining with the anti-Abcb11 and the anti-Abcc6 antibodies 
clearly delineated the canalicular and the sinusoidal com-
partments, respectively (Figure 1C). Immunohistochemical 
studies performed on frozen human liver sections gave identi-
cal results (Figure 1E). Furthermore, cross-sectional analysis 
of the confocal images indicated that Abcc6 is uniquely local-
ized in the PM (Figure 1G).
In line with the lack of apparent intracellular staining in 
frozen liver sections, we were unable to detect colocalization 
between Abcc6/ABCC6 and the mitochondrial marker 
cytochrome C oxidase (complex IV) (CoxIV) (Figure 2A and 
2C) or the endoplasmic reticulum/MAM-specific anticalnexin 
antibody (Figure 2B). To corroborate our findings, we have also 
analyzed cultured primary mouse hepatocytes from wild-type 
and Abcc6−/− mice. Cells were treated with MitoTracker Red 
before fixing and immunostaining with 2 different monoclonal 
antibodies recognizing Abcc6. Consistent with the results 
obtained with frozen tissue sections, Abcc6 was exclusively 
found in the PM of primary hepatocytes (Figure 2D and 2E), 
showing colocalization with catenin (not shown) but not with 
MitoTracker Red (Figure 2D and 2E).
Nonstandard Abbreviations and Acronyms
MAM mitochondria-associated membrane
PM plasma membrane
Figure 1. Colocalization of the mouse Abcc6 and human ABCC6 proteins with various plasma membrane markers in mouse and 
human liver samples. A, The monoclonal antibody M6II-68 revealed the plasma membrane localization of Abcc6 (green), which clearly 
colocalized (yellow) with the plasma membrane marker cadherin (red). B, The combined use of the polyclonal antibody S-20 specific 
to the mouse Abcc6 (red) and an antibody recognizing the basolateral plasma membrane marker Na,K-ATPase (green) also showed 
significant overlap with large areas of colocalization (yellow). C, The monoclonal antibody recognizing Abcb11 (TU236) delineates the 
canalicular (apical) membranes of hepatocytes (red), whereas the anti-Abcc6 M6II-68 labels the basolateral plasma membrane (green). 
Minimal colocalization is visible. D, Immunofluorescence staining of frozen human liver sections with the monoclonal antibody recognizing 
human ABCC6 (M6II-7, green) or the plasma membrane marker cadherin (red) shows evidence of colocalization. E, The anti-ABCC6 
antibody M6II-7 and the anti-ABCB11 monoclonal antibody TU236 reveal plasma membrane staining but at distinct plasma membrane 
compartments (ABCC6, green, basolateral; ABCB11, red, canalicular or apical). F, The strong punctuate staining (yellow) on D and E 
represents nonspecific fluorescent signals often encountered in human liver cells as evidenced by the negative control staining performed 
without primary antibodies. G, Z-stack projections obtained of frozen mouse liver sections and stained with the M6II-68 antibody. All 
images were collected by confocal microscopy, except for those of B that were obtained by a standard fluorescent microscope. Nuclei 
were counterstained with 4',6-diamidino-2-phenylindole (blue).
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Discussion
To elucidate the physiological role of ABCC6 in ectopic calci-
fication, the exact subcellular localization of the native protein 
must be firmly established. We have performed experiments 
to reveal the localization of the ABCC6 protein in its natural 
tissue environment. Sharply contrasting the findings of Martin 
et al6 and consistent with previously published literature re-
garding the rat,8 mouse,7,9 and human ABCC6 proteins,10,12 we 
unequivocally show that the ACBC6 protein is expressed in 
the basolateral PM (Figure 1). Furthermore, we detected no 
significant intracellular localization for Abcc6/ABCC6 using 
the same markers used by Martin et al6 for labeling mitochon-
dria, the endoplasmic reticulum, and MAM organelles. The 
same conclusion could be drawn in a second experimental 
setup using primary mouse hepatocytes (Figure 2).
Contrary to the methods used by Martin et al,6 our methods 
avoided multistep fractionation of homogenized hepatic tissue 
samples. It is worth noting that cell disruption and fractionation 
experiments have led to inaccurate conclusions concerning the 
(intra)cellular localization of membrane-embedded proteins.13 
Martin et al6 found no evidence of PM expression of Abcc6 by 
cell surface biotinylation of primary hepatocytes. Based on the 
overwhelming evidence of our experiments, we believe that the 
lack of biotinylation should be explained by the unavailability of 
surface biotinylation targets. Indeed, our topology analysis sug-
gests that the extracellular loops of ABCC6 are relatively short 
and contain only 2 potentially reactive lysine residues.
The precise biosynthetic pathway and the mechanisms reg-
ulating the PM targeting of ABCC6 are still largely unknown, 
yet a recent study has suggested a role for endoplasmic re-
ticulum chaperones in cellular trafficking.5 The present study 
has reestablished that ABCC6 is mainly localized in the PM, 
which is probably where the physiological action of the pro-
tein is exerted.
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Antibodies 
The primary antibodies to mouse Abcc6 (sc-5787), β -catenin (Sc-7199), and NA,K- ATPAse 
(sc-28880) were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). The 
anticadherin (Ab16505) and anticalnexin (10286) antibodies were purchased from Abcam 
(Cambridge, MA). AntiCoxIV (3E11) rabbit mAb was from Cell Signaling Technology, Danvers, 
MA, USA. The Rat M6II-7 and M6II-68 monoclonal antibodies were generous gifts from George 
Scheffer (University Medical Center Amsterdam), while the polyclonal antibody TU236 was 
kindly provided by Daniel F. Ortiz (Tufts University, Medford, Ma)., The appropriate secondary 
antibodies were Alexa Fluor 488 and Alexa Fluor 594 (Invitrogen, Carlsbad, CA). 
Immunochemistry of frozen liver sections 
For immunohistochemical staining of mouse liver samples C57BL/6 mice were used, and 
Abcc6-/- mouse strain was used as negative control to prove the specificity of anti- Abcc6 
antibodies. Mice were terminated by cervical dislocation, multiple liver lobes were quickly 
harvested, placed in Optimum Cutting Temperature (OCT) compound and stored at -800C. 
Human frozen normal liver sections were prepared and stained at the 1st Pathology 
Department, Semmelweis University as approved by the Ethical Committee of Semmelweis 
University of Budapest. Immunofluorescent staining of liver tissues was performed using 8 µm- 
frozen sections. Samples were fixed with ice-cold methanol for 5 min and rinsed 3 times for 5 
min in DPBS (PBS + 1 mM CaCl2 + 0.5 mM MgCl2). The samples were then blocked for 30 
min in DBPS with 2mg/ml BSA, 1% fish gelatin, 0.15 % Triton X-100, 5% of the appropriate 
serum). Mouse liver sections were stained with a rat monoclonal anti-Abcc6 antibody (M6II-68) 
as described [2], or the goat polyclonal anti-Abcc6 antibody (S-20) to specifically detect Abcc6. 
The human ABCC6 protein was detected on the human liver samples using anti-ABCC6 
monoclonal antibody M6II-7 [1]. As colocalization markers, the primary antibodies against 
cadherin, β- catenin, Na,KATPase or Abcb11/Bsep were used. Images were obtained with an 
Axioscope 2 fluorescent microscope (Zeiss, Thornwood, NY) and a Zeiss LSM 710 confocal 
laser scanning microscope. 
Isolation and culture of mouse hepatocytes 
Experiments were carried out by using hepatocytes prepared from female C57BL/6 mice 
(weighing 20 g). Liver cells were isolated by the published method [2]. Hepatocytes having 
viability better than 90%, as determined by trypan blue exclusion, were used in the 
experiments. Cells were plated in collagen-precoated dishes in serum containing medium 
described [3]. After attachment of cells medium was changed and renewed every 24h in the 
absence of serum. Treatment with MitoTracker Red CMXRos (Life Technologies,Grand Island, 
NY, USA) was perfored at 200 nM concentration for 30 minutes at 370C and subsequent 
fixation with 4% paraformaldehide, immunocytochemistry and confocalimaging was 
carried out after 72 hours of cell culturing. 
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Supplemental Figure I. 
Controls for antibody specificity. Neither with frozen liver sections nor with isolated 
primary hepatocytes from Abcc6-/- mice, the polyclonal antibody S-20, the monoclonal 
antibodies M6II-68 and M6II-24 gave specific fluorescent signal proving the high 
specificity of the immunochemical results of the present study. Nuclei were 
counterstained with DAPI (blue). 
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